A team of Japanese researchers is developing a medication that enables tooth regrowth. The innovative drug will target individuals lacking a complete set of adult teeth due to congenital factors such as anodontia. Clinical trials are set to begin in 2024, with the aim of making the drug available by 2030. The breakthrough could impact dental treatments such as dentures or implants.
Group-IB’s Threat Intelligence and Defence Centre Equip Undergraduates with Sophisticated Cybersecurity Technologies to Boost Threat Analysis and Enhance Cyber Resilience for Campus Start-ups
Hey there from the heart of the San Francisco Bay Area! It’s an absolute pleasure to have you back again for our chat on some
